LSC
WVE icon

Lesa Sroufe & Co’s Wave Life Sciences WVE Stock Holding History

Lesa Sroufe & Co’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-6,440
Closed -$226K – 60
2017
Q4 		$226K Buy
+6,440
New +$188K 0.19% 38
2016
Q4 		– Sell
-6,440
Closed -$209K – 47
2016
Q3 		$209K Buy
+6,440
New +$152K 0.18% 39

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BM
Bridger Management New York $150M AUM 17.71% 1-Year Est. Return

Lesa Sroufe & Co's WVE Position: Q1 2018 in Review

Lesa Sroufe & Co sold out of Wave Life Sciences (WVE) in Q1 2018, closing a stake of 6,440 shares — an estimated $226K sold.

Lesa Sroufe & Co first reported a position in WVE in Q3 2016 and held it in 2 quarters. The position peaked at $226K in Q4 2017. 79 funds tracked by Wall St. Rank hold WVE as of Q1 2018.

  • Lesa Sroufe & Co reported no remaining Wave Life Sciences position as of Q1 2018 after selling out during the quarter.
  • Lesa Sroufe & Co sold 6,440 Wave Life Sciences shares in Q1 2018, an estimated $226K.
  • Lesa Sroufe & Co first reported a position in Wave Life Sciences in Q3 2016 and held it in 2 quarters.
  • Lesa Sroufe & Co's Wave Life Sciences position peaked at $226K in Q4 2017.
  • 79 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2018.

Based on Lesa Sroufe & Co's 13F filing for Q1 2018, filed 9 Apr 2018.